“Many COVID-19 patients get secondary infections that are bacterial, so I built my whole exam around it. Students were given data and had to use GIDEON to analyze the secondary infection, how it should be treated, whether it will contribute to COVID-19 resistance, so the role play continued even during the exams.”

<…> Notably, in 2017, dengue outbreaks were reported from eight Sub-Saharan countries reaching an excess of 21,000 total cases. Burkina Faso recorded more than half of these cases (13,135) including 28 deaths (Gideon, 2018).

“Here, we examine the global trends between changes in forest cover in recent decades and epidemics of human infectious diseases, using the GIDEON global database, which is the best available data set on infectious diseases that has already been used in several studies.”

“The new version of GIDEON sports a fundamentally redesigned user interface with convenient additions to responsive design and accessibility. <..> This makes GIDEON less of a reference-only resource and more of a hybrid information and diagnosis tool more immediately usable by public health practitioners. “

“While the world’s focus has been on COVID-19, sometimes it seems like nothing else is happening in infectious diseases. But that is far from the reality.

In recent years, we’ve seen Nigeria report large numbers of Lassa fever, we continue to see plague outbreaks from Africa to Asia and monkeypox cases have risen in recent decades.

Joining me to talk about these other outbreaks is Stephen A. Berger, M.D.   Dr. Berger is the co-founder of GIDEON Informatics (Global Infectious Diseases and Epidemiology Network).”

“Most viruses that cause human disease are named for the disease itself,” said Stephen Berger, a founder and medical adviser at the Global Infectious Diseases and Epidemiology Network, in an email. “The virus that causes measles is called ‘Measles virus’ and the virus of influenza is called ‘Influenza virus.’ ”

Dr. Stephen Berger, double board certified in infectious disease and microbiology and the founder of GIDEON, the Global Infectious Disease and Epidemiology Network, explains to Eat This, Not That! Health that he and his team have been working with a “Computer Expert [Decision Analysis] System” designed to generate a list of diseases based on signs and symptoms. The list is ranked according to statistical probability.

With the help of decision support tools, clinicians can differentiate between vector-borne diseases during a season where more people are at risk. A decision support system uses two or more items of patient data to generate case-specific advice. In practical terms, the output of such systems is used to arrive at a specific diagnosis. Although none of these systems can “make” a diagnosis, they are capable of generating a list of diseases that are compatible with a patient’s epidemiological background, signs, symptoms, and laboratory findings.

…

Stephen A. Berger is cofounder and medical director of GIDEON, the Global Infectious Disease and Epidemiology Online Network.

For example, if a group of American adults is experiencing severe illness, cough and fever, the most likely diagnosis is COVID-19. In this scenario, an infectious disease database platform ranks COVID-19 “number 1,” with a statistical likelihood of 87%. However, the program also lists an additional 76 infectious diseases. (Influenza is the second most likely diagnosis, with a probability of 8%.)

…

Stephen A. Berger, MD, is cofounder and medical director of GIDEON, the Global Infectious Disease and Epidemiology Online Network.

… if you want to make your voice heard at a protest, know that there are ways to lower your risk of catching—or spreading—COVID-19
…
“Assume that the stranger standing next to you is spreading the virus,” adds Stephen Berger, M.D., infectious disease expert and founder of the Global Infectious Diseases and Epidemiology Network (GIDEON).

Think long and hard before deciding to meet up with friends or family. Your own health is a priority, and you want to be considerate of others, too.

Contracting COVID-19 is a lot about the company you keep, explains Stephen Berger, MD, infectious disease expert and co-founder of GIDEON (Global Infectious Diseases and Epidemiology Network). But the places you go can make a difference, too.

“Infectious material enters our body through our mouth or nose — either because you were within a few feet of a human carrier, or because something brought this material to the area of our face,” Dr. Berger says.